期刊文献+

布洛芬固体分散体的制备及其物相鉴别研究

Preparation and Phase Identification of Ibu-profen Solid Dispersion
下载PDF
导出
摘要 目的:为改善难溶性药物布洛芬的体外溶出度。方法:以聚乙烯聚吡咯烷酮和聚乙二醇为载体,比较溶剂法和熔融法制备布洛芬固体分散体的溶出度,并考察和确定制备条件。通过差示扫描量热分析、粉末X射线衍射分析和扫描电子显微镜分析法对固体分散体进行物相鉴别。结果:两种方法制备的布洛芬固体分散体能显著提高布洛芬的体外溶出度(P 【0.001,P 【0.001)。在最佳制备条件下,2 h内累计溶出度均可达到80%以上。但二者在速度上有差别,10 min时溶剂法和熔融法制备的布洛芬固体分散体累计溶出度为65.10%和38.69%,体外溶出速率是原料药的3.60倍和2.14倍,溶剂法比熔融法的溶出效果更好。结论:固体分散体技术可提高布洛芬等难溶性药物的溶出度。 Objective: To improve the in vitro dissolution of the insoluble drug Ibuprofen. Methods: Using Polyvinylpyrrolidone and polyethylene glycol as carriers, the dissolution of Ibuprofen solid dispersions prepared by the solvent method and melt method was compared, and the preparation conditions were investigated and determined. Differential scanning calorimetry, powder X-ray diffraction and scanning electron microscopy were used for phase identification. Results: The Ibuprofen solid dispersions prepared by the two methods could significantly improve the in vitro dissolution of Ibu-profen (P
机构地区 贵州大学药学院
出处 《药物资讯》 2020年第1期7-16,共10页 Pharmacy Information
基金 国家自然科学基金(NFSC 21562014) 贵州大学SRT (No.191).
  • 相关文献

参考文献5

二级参考文献89

  • 1郑杨,张志丽,王立红,礼彤,郭永学,周丽莉.非诺贝特固体分散体制备工艺研究及比较[J].中国药剂学杂志(网络版),2012(2):26-34. 被引量:10
  • 2洪涛,欧阳五庆.固体分散体的载体选择及质量评价的新进展[J].黑龙江畜牧兽医,2004(9):84-86. 被引量:3
  • 3VASCONCELOS T, SARMENTO B, COSTA P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs [J]. Drug Discov Today, 2007, 12(23/24): 1068-1075. 被引量:1
  • 4KAWAKAMI K. Current status of amorphous formulation and other special dosage forms as formulations for early clinical phases [J]. J Pharm Sci, 2009, 98(9): 2875-2885. 被引量:1
  • 5JANSSENS S, MOOTER G. Review: physical chemistry of solid dispersions [J]. J Pharm Pharmacol, 2009, 61(12): 1571-1586. 被引量:1
  • 6BHUGRA C, PIKAL M J. Role of thermodynamic, molecular, and kinetic factors in crystallization from the amorphous state,J]. J Pharm Sci, 2008, 97(4): 1329-1349. 被引量:1
  • 7CHOKSHI R J, ZIA H, SANDHU H K, et al. Improving the dissolution rate of poorly water soluble drug by solid dispersion and solid solution: pros and cons [J]. Drug Deliv, 2007, 14(1): 33-45. 被引量:1
  • 8WEUTS I, KEMPEN D, VERRECK G, et al. Study of the physicochemical properties and stability of solid dispersions of loperamide and PEG6000 prepared by spray drying [J]. Eur J Pharm Biopharm, 2005, 59(1): 119-126. 被引量:1
  • 9VAN DEN MOOTER G, WUYTS M, BLATON N, et al. Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25 [J]. Eur J Pharm Sci, 2001, 12(3): 261-269. 被引量:1
  • 10TAYLOR L S, ZOGRAFI G. Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions [J]. Pharm Res, 1997, 14(12): 1691-1698. 被引量:1

共引文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部